UNIGE document Scientific Article
previous document  unige:84375  next document
add to browser collection
Title

Conversion of cyclosporine A prodrugs in human tears vs rabbits tears

Authors
Hamel, A R
Hubler, F
Wenger, R
Mutter, M
Besseghir, K
show hidden authors show all authors [1 - 9]
Published in European Journal of Pharmaceutics and Biopharmaceutics. 2005, vol. 59, no. 1, p. 51-56
Abstract The aim of this study was to evaluate the rate and mechanism of conversion of two water-soluble prodrugs of cyclosporine A (CsA) intended for topical delivery to the eye. The new molecules were designed according to the double prodrug concept: a solubilizing moiety was grafted onto CsA via an ester function, which could be hydrolysed via a two-step process (enzymatic and chemical). Prodrug solutions were prepared extemporaneously in an isotonic and neutral aqueous medium compatible with ophthalmic use. The rates of conversion into the parent molecule were determined by incubating the prodrugs in fresh rabbit or human tears or in a phosphate buffer solution (PBS) at pH 7.4. Both prodrugs were converted into CsA within the first minute in the presence of rabbit tears with rate constants of k=5.9x10(-3)min(-1) and k=3.8x10(-3)min(-1), respectively, for UNIL088 and UNIL089, whereas chemical conversion in PBS was negligible (k=0.5x10(-3)min(-1) for both molecules). Incubation of UNIL088 in human tears showed a significantly high conversion rate. It is concluded that the developed double prodrugs underwent a bioconversion in physiological media and thus represent promising candidates for topical delivery of CsA to the eye.
Keywords AnimalsCyclosporine/chemistry/pharmacokineticsHumansProdrugs/chemistry/pharmacokineticsRabbitsTears/metabolism
Identifiers
PMID: 15567301
Full text
Article (Published version) (129 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Citation
(ISO format)
LALLEMAND, Frédéric et al. Conversion of cyclosporine A prodrugs in human tears vs rabbits tears. In: European Journal of Pharmaceutics and Biopharmaceutics, 2005, vol. 59, n° 1, p. 51-56. https://archive-ouverte.unige.ch/unige:84375

75 hits

0 download

Update

Deposited on : 2016-06-09

Export document
Format :
Citation style :